Evidence map›Paper›PMID 29241042›Full record

ArticleCell host & microbe2017

The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling.

Nathan R Zemke, Arnold J Berk

Open access · greenAbstract read
In one paragraph

Article in Cell host & microbe, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 33 citations in OpenAlex.

  1. Interferon regulatory factors orchestrate CD8International journal of molecular medicine · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Identification of a novel, pathogenicFrontiers in genetics · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Nathan R ZemkeMolecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095-1570, USA.
Arnold J BerkMolecular Biology Institute, University of California, Los Angeles, Los Angeles, CA 90095-1570, USA; Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095-1570, USA. Electronic address: berk@mbi.ucla.edu.
University of California, Los Angeles · US

Funding

Interdisciplinary Training in Virology and Gene TherapyT32AI060567 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WU, TING-TING · 2004 to 2018
$3.4M
BIOSYNTHESIS OF ADENOVIRUS EARLY RNASR01CA025235 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BERK, ARNOLD J · 1985 to 2016
$2.7M
NCI NIH HHS R01 CA025235NIAID NIH HHS T32 AI060567
6 · The paper itself

Abstract

The N-terminal half of adenovirus e1a assembles multimeric complexes with host proteins that repress innate immune responses and force host cells into S-phase. In contrast, the functions of e1a's C-terminal interactions with FOXK, DCAF7, and CtBP are unknown. We found that these interactions modulate RAS signaling, and that a single e1a molecule must bind all three of these host proteins to suppress activation of a subset of IFN-stimulated genes (ISGs). These ISGs were otherwise induced in primary respiratory epithelial cells at 12 hr p.i. This delayed activation of ISGs required IRF3 and coincided with an ∼10-fold increase in IRF3 from protein stabilization. The induced IRF3 bound to chromatin and localized to the promoters of activated ISGs. While IRF3, STAT1/2, and IRF9 all greatly increased in concentration, there were no corresponding mRNA increases, suggesting that e1a regulates the stabilities of these key activators of innate immune responses, as shown directly for IRF3.

Indexed as

Host-Pathogen InteractionsImmune EvasionImmunity, InnateSignal TransductionAdaptor Proteins, Signal TransducingAdenoviridaeAdenovirus E1A ProteinsAlcohol OxidoreductasesCells, CulturedDNA-Binding ProteinsEpithelial CellsForkhead Transcription FactorsHumansInterferon Regulatory Factor-3Protein BindingAdaptor Proteins, Signal TransducingAdenovirus E1A ProteinsAlcohol OxidoreductasesC-terminal binding proteinDCAF7 protein, humanDNA-Binding ProteinsForkhead Transcription FactorsFOXK1 protein, humanInterferon Regulatory Factor-3IRF3 protein, humanadenovirusCtBPDCAF7DYRK1AE1AFOXKIFN-stimulated genesinterferon responseIRF3RAS

Identifiers

PMID29241042
PMCPMC5736016
OpenAlexW2774651309

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.